Oculis
Series COculis raised €47M in a Series C round in May 2021. The company is based in Lausanne, Switzerland. Investors in the round: Bay City Capital, Brunnur Ventures, BVCF Management and 9 others. Data as of Nov 2026.
Amount raised
€47M
€47,480,217
Native amount
57,000,000 USD
Stage
Series C
series c
Investors
12
Provenance & confidence
High confidenceAmount
57,000,000 USD
ECB-at-date → €47M · rate 1.2005 on 2021-05-05
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
12 namedBay City CapitalBrunnur VenturesBVCF ManagementEarlybird Venture CapitalHyfinity InvestmentsNan Fung Life SciencesNovartis Venture FundPivotal bioVenture PartnersSilfurbergTekla Capital ManagementVI PartnersWille AG
Date
May 2021
Round type
series c
Amount (EUR)
€47M